Summary: Trauma-induced multiple organ failure in sheep was prevented by aprotinin therapy.
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sheep model with septic shock, the inhibition of kalli-krein by aprotinin prevented systemic vasodilatation and pulmonary hypertension (18) . Therefore, our aim was to evaluate whether inhibition of the main target enzymes (plasmin, kallikrein) by aprotinin in a trauma-induced sheep model of multiple organ failure would improve organ functions and prevent multiple organ failure development.
Materials and Methods
Animal preparation, haemodynamic and cardio-respiratory measurements All procedures were performed according to the German council's guide for the care and use of laboratory animals of August 18, 1986 and were approved by the animal protection committee of the local government (No. 93600). Adult female merino sheep were used, weighing 25-30 kg. To produce multiple organ failure, the animals were treated as previously described (9, 10) . Briefly, at day 0 a venous catheter was placed into the right jugular vein under local anaesthesia and blood was drawn and anticoagulated with sodium citrate for basic measurements. General anaesthesia was induced with 0.5 mg Atropin® and 3.5 mg/kg body weight Pentobarbital® and was continued by ventilation with halothane/nitrogen oxide/oxygen after intubation. Further catheters were placed into the femoral vein and artery, a Swan-Ganz thermodilution catheter (Baxter model 93 A-131-7F, Edwards Critical Care Division, Irvine, CA, USA) was inserted via an external jugular vein and advanced into the pulmonary artery.
Another catheter was located into the urinary bladder (Norta, Modell 10 -No. 9385, BDF Beiersdorf AG, Hamburg, Germany) and connected with a collection tube. Arterial, central venous, pulmonary arterial and pulmonary capillary wedge pressure were recorded using pressure transducers which were positioned at the level of the right atrium. Calibration was done prior to each measurement. Cardiac index was measured by the thermodilution method. In heparinized arterial and mixed venous blood samples, acidity, carbon dioxide, oxygen tension, and oxygen saturation were recorded using a blood gas analyser (ABL2, Radiometer, Copenhagen, Denmark).
Alveolar-to-arterial oxygen pressure difference, right ventricular stroke work index, pulmonary vascular resistance, and arterio-tovenous oxygen pressure difference were calculated by standard formulae from the quantities measured. Blood (anticoagulated with sodium citrate) for biochemical measurements was drawn every day in the morning before each treatment.
During the experiment the animals did not receive any further operative treatment and had free access to food and water. The animals were observed for a total of 11 days and then sacrificed under anaesthesia by infusion of 0.1 ml/kg T61 (Embutramid + Mebezoniumiodide + Tetracin hydrochloride; Hoechst AG, Frankfurt, Germany).
Bronchoalveolar lavage technique
Bronchoscopy and bronchoalveolar lavage were performed with a fiberoptic bronchoscope (Olympus BF type l T 10, Olympus Corporation of America, New Hyde Park, N. Y., USA) as previously described (19) . Under light anaesthesia (1.5 mg/kg thiopental sodium and subsequent injection of 2 mg/kg pentobarbital) the bronchoalveolar lavage procedure was performed at days 0 (prior to the induction of haemorrhagic shock), day 6, and day 10 before each medication/treatment.
Haemorrhagic shock and intramedullary femoral nailing
After bronchoscopy blood was drawn in 50 ml portions until the mean arterial pressure was 6.7 kPa. This was maintained for 2 hours by fractional blood withdrawal. The total blood volume collected was 450-600 ml (about 20 ml/kg). Then, a three-times volume of Ringer-lactatQ solution and 5 mg/kg aprotinin 2 ) in a total of 5 ml of saline were infused (aprotinin was given only in the treatment group) until the mean arterial blood pressure reached a normal level. This was followed by a closed intramedullary femoral nailing procedure with a standard AO technique (20) .
• · · Administration of endotoxin and zymosan-activated plasma After overnight recovery, haemodynamic and cardio-respiratory quantities were measured and blood was drawn (anticoagulated with sodium citrate) for the biochemical measurements. Then, 0.7 ml/kg zymosan-activated autologous plasma + 0.75 μg/kg endotoxin were injected in 5 ml of saline simultaneously with 5 mg/kg (= 35 695 KIU/kg) aprotinin in 5 ml of saline (aprotinin group; η = 6) and without aprotinin (control group; η = 10). This administration was repeated every 12 hours for a total of 5 days, and baseline measurements were performed every day in the morning before each application.
Endotoxin, zymosan-activated plasma and aprotinin preparations Escherichia coli endotoxin (serotype 055:B5, Sigma Chemicals, Deisenhofen, Germany) was dissolved in saline and applicated in a total of 5 ml of saline to yield 0.75 μg/kg. For the production of zymosan-activated plasma, 450 ml blood (anticoagulated with sodium citrate) were withdrawn at day 0 and centrifuged for 10 min at 800 g and 22 °C. The plasma was then incubated with sterile zymosan (3 mg/ml plasma) (zymosan A, Sigma Chemicals, Deisenhofen, Germany; sterilized at 120 °C, 203 kPa absolute pressure, 20 min) for 30 min at 30 °C with agitation. After centrifugation for 15 min and 800 g at 22 °C, 25 ml portions of the supernatant were frozen at -25 °C. Aprotinin (Trasylol®, Lot. No. 9011; 7139 KIU/mg polypeptide; Bayer AG, Wuppertal, Germany) was dissolved in sterile saline (1 g/30 ml) and applied at a concentration of 5 mg/kg.
Biochemical measurements
The following quantities were determined in citrated plasma, bronchoalveolar lavage fluid or urine. , creatinine, bilirubin and urea, using test combinations (Boehringer, Mannheim, Germany). Total protein was determined by the biuret method, albumin by the bromocresol green method (22) . Cell counting was performed in a Neubauer haemocytometer after staining with Turk's solution. The chemiluminescence response of citrated blood and isolated neutrophils was measured according to previously described methods (19, 22, 23) , in a sixchannel Biolumat LB 9505 (Berthold, Wildbad, Germany). Peak maximum values of zymosan-induced photori emission (counts/ min· 25 000 neutrophils of isolated cell measurement; counts/rnin • 250 000 neutrophils of blood measurement) were calculated as a measure of the total metabolic capacity/activity, non-induced pho* ton emission (spontaneous) as a measure of in vivo activation by inflammatory mediators, and peak time values (min) as a measure of the surface receptor expression on neutrophils. Urine aprotinin concentration was measured according to 1. c. (24) 
Results

Cardiac function and haemodynamics
The cardiac index increase for the control group became significant at days 8-10, whereas cardiac index for the aprotinin group remained in a normal range during the total observation period. There were significant differences between control and aprotinin groups at day 10 (fig. la).~ Systemic vascular resistance decreased significantly for the control group at days 7, 8 and 10, whereas there was only an initial decrease of systemic vascular resistance for the aprotinin group at day 2 with a complete recovery till day 5 and with a constant level up to day 10 ( fig. lb) .
Mean arterial pressure increased for the control group and remained unchanged for the aprotinin group. Between-group differences were significant at days 6, 8-10 ( fig. Ic) .
Pulmonary function
Pulmonary arterial oxygen tension fell constantly till day 10 in both groups. There were significant differences between the groups at days 6 and 10 ( fig. 2a) . Pulmonary vascular resistance increased till day 10 in the control group, whereas there was no definite movement in the aprotinin group. Significant differences between the groups were observed at day 8 ( fig. 2b ). Mean pulmonary arterial pressure increased significantly at days 7-10 in the control group, but did not change in the aprotinin group during the total observation period. Significant differences between the groups became obvious at days 3 -10 ( fig. 3a) . The epithelial lining fluid/ plasma ratio of albumin concentrations increased significantly after 6 and 10 days in the control group; there were significant differences between the groups after 10 days ( fig. 3b) . 
Liver function
After an initial reversible increase of the plasma sorbitol dehydrogenase of control animals at day 1 there was a late increase which became significant at day 9, whereas aprotinin group values remained low for the total observation period. Between-group differences were significant at day 10 ( fig. 4a ).
Plasma biiirubin concentrations in the control group indicated an increase that became significant at days 9 and 10, whereas there was only a slight increase in the aprotinin group. The differences »between the groups were significant at days 8-10 ( fig. 4b ).
Kidney function
Creatinine clearance of the control group was normal till day 5, then declined significantly at days 9 and 10, whereas the aprotinin group indicated low values for the total period; between group differences were significant at day 5 ( fig. 5a ). The plasma urea concentration differed only at day 10, in that the control group demonstrated non-significantly higher values ( fig. 5b) . The daily total amount of aprotinin eliminated with the urine peaked at day 3 and then fell despite further aprotinin administration ( fig. 6 ). 
General cytoprotection
Plasma lactate dehydrogenase of the control group increased significantly at day 10, whereas in the aprotinin group lactate dehydrogenase decreased steadily but non-significantly from the first day onwards. There were significant differences between the groups at days 9 and 10 ( fig. 7) .
ι" Neutrophil count and function in blood and epithelial lining fluid Neutrophil count in blood increased significantly at day 10 for the control group and at days 6 and 9 for the aprotinin group; significant differences between the groups were observed at days 3, 6 and 7 ( fig. 8a ). Absolute neutrophil count in epithelial lining fluid increased significantly after 6 days for the control group, whereas aprotinin goup values remained low ( fig. 8b) . Calculation of the releative portions of alveolar neutrophils showed a significant increase after 6 and 10 days for the control group (fig. 8c ).
The chemiluminescence response to zymosan by neutrophils isolated from the blood demonstrated a nearly unchanged course for the control group over the total observation period and a decrease of the aprotinin group till day 6 with subsequent recovery; the difference at day 6 between the two groups was significant ( fig. 9a ). The chemiluminescence response of neutrophils isolated from the epithelial lining fluid showed a significant decrease at day 6 for the control group, but there was no significant difference between control and aprotinin groups ( fig. 9b) . The chemiluminescence response difference of blood-and epithelial lining fluid-derived neutrophils (this difference indicates the loss of metabolic capacity of neutrophils during their capillary-interstitialalveolar passage and is a measure of the amount of reactive oxygen metabolites produced) increased significantly at day 6 for the control group, and there was a significant difference between the two groups at day 6 ( fig. 10) . The spontaneous non-stimulated chemiluminescence response, indicating the in vivo production and stimulatory effect of inflammatory mediators, increased for both groups, but was significantly higher for the control group at day 6 ( fig. 11 a) . The time taken to reach the photon emission maximum, indicating neutrophilic C3b receptor expression, decreased for the control group and increased for the aprotinin group; there were significant differences between the groups at days 2, 8 and 9 ( fig. lib) . 
Discussion
Extensive neutrophil and endothelial cell activation and interaction can result in the destruction of endothelial and parenchymal structures, and in organ failure. Important mediators of these reactions are reactive oxygen metabolites and proteinases which can induce each other's production, especially that of oxygen and nitric oxide radicals by blood cascade system proteinases. This can happen by direct or non-direct, i. e. complement-, fibrinolysis-or coagulations-associated reactions ( fig. 12) .
The main target enzymes of aprotinin, plasmin and plasma kallikrein, are supposed to mediate neutrophil and endothelial cell activation. Therefore, the inhibition of these enzymes by aprotinin was expected to reduce inflammatory mediator production below the level that causes irreversible organ damage. To prove this assumption, we used an animal model of multiple organ failure which included the most important humoral and cellular activation steps shown after multiple injuries in humans (9, 10) . In this model, sheep were subjected to haemorrhagic shock, intramedullary femoral nailing and repeated administration of endotoxin and zymosan-activated plasma for 5 d^ys. The animals of the control group developed an irreversible sequential multiple organ failure between 6 and 10 days, as was demonstrated by monitoring the functional quantities of different organs (10) . By a simultaneous treatment with aprotinin the significant alteration/impairment of several organ functions could be avoided, resulting in the healing of the experimentally induced multiple organ failure development. Judged by different functional quantities, two out of five organs/systems monitored demonstrated an absolute and significant improvement. Bilirubin as a marker of excretory and detoxicative liver functions and sorbitol dehydrogenase as a marker of hepatocyte membrane integrity indicated a significant improvement of liver function.
Furthermore, a general cytoprotective effect of aprotinin presumably comprising all organs was observed by measuring plasma lactate dehydrogenase.
Concerning the lung, there was no unique behaviour of functional quantities. Three of them normalised with aprotinin therapy (pulmonary vascular resistance, mean pulmonary arterial pressure, epithelial lining fluid/ plasma ratio of albumin as a direct biochemical marker of the lung capillary permeability damage (25)), whereas one of them remained pathological (pulmonary arterial oxygen tension). Therefore, the term 'improvement of lung function' should be restricted to defined lung quantities considered in this context.
The only organ without perceptible amelioration by aprotinin was the kidney. Previously described renal effects of aprotinin (26) were also found in the depression of the creatinine clearance for the total observation period without tendency to improve. In contrast, Cumming et al. found an aprotinin-induced improvement of the renal function in an acute sheep model of septic shock (18) . This may be explained by the difference of the models used. The plasma urea concentration fell only insignificantly at day 10, and the aprotinin excretion into the urine decreased from day 3 onwards, despite continuous administration of aprotinin, indicating the early impairment of the renal function.
The pathophysiology of this type of induced organ failure seems to be associated with neutrophil dysfunction (3, 8, 27) and is assumed to be identical in different organs. But, because of its unique anatomy, the lung in particular offers the experimental design for easily isolating and investigating neutrophils before (capillary neütrophils) and after (alveolar neutrophils) they have participated in the destructive processes of organ failure during their capillary-interstitial-alveolar transition.
Thus, the increased alveolar influx of neutrophils, already previously observed (19, 28) , indicated the participation of neutrophils, chemotaxins like IL-8 or C5a (29) and reactive oxygen metabolites (30) . This neutrophil influx seemed to be reduced by the aprotinin-induced inhibition of plasmin-and kallikrein-associated chemotaxin formation ( fig. 12 ). The aprotinin-induced reduction of inflammatory mediator production was reflected by the reduction of the spontaneous photon emission of isolated neutrophils which had experienced less in vivo priming by different amounts and/or types of inflammatory mediators (31, 32) . This was confirmed by the aprotinin-mediated reduction of in vivo neutrophil activation, measured by the increase of the time taken to attain the photon emission maximum of in vitro zymosan-activated neutrophils, representing a reciprocal measure of in vivo C3b receptor expression by inflammatory mediator-induced activation (23) .
The difference between the in vitro-induced reactive oxygen metabolite production of simultaneously isolated blood neutrophils and epithelial lining fluid neutrophils was used as an index of lung tissue damage by neutrophils during their passage from the capillary into the alveolus. For animals of the control group, which developed multiple organ failure, this difference was significantly higher in comparison with aprotinin-treated animals which did not develop multiple organ failure.
The greater extent of control neutrophil priming by a higher amount and/or more effective inflammatory mediators (as observed by the higher in vitro response of control neutrophils) enables neutrophils in vivo and in vitro to increase their reactive oxygen metabolite production upon secondary stimulation and to produce a higher degree of tissue damage. Since aprotinin prevents the plasmin-and kallikrein-associated production of priming inflammatory mediators, it contributes to the reduction of reactive oxygen metabolites produced by secondary stimulation and to the reduction of tissue destruction.
In summary, by the inhibition of plasmin-and kallikreinmediated pathways, aprotinin improved the function of several injured organs, except kidney, and thus, prevented at least partially the development of an experimentally induced multiple organ failure in sheep.
